BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 9362448)

  • 1. Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma.
    Ford CA; Petrova S; Pound JD; Voss JJ; Melville L; Paterson M; Farnworth SL; Gallimore AM; Cuff S; Wheadon H; Dobbin E; Ogden CA; Dumitriu IE; Dunbar DR; Murray PG; Ruckerl D; Allen JE; Hume DA; van Rooijen N; Goodlad JR; Freeman TC; Gregory CD
    Curr Biol; 2015 Mar; 25(5):577-88. PubMed ID: 25702581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 antisense therapy in B-cell malignant proliferative disorders.
    Chanan-Khan A; Czuczman MS
    Curr Treat Options Oncol; 2004 Aug; 5(4):261-7. PubMed ID: 15233903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A caspase-resistant form of Bcl-X(L), but not wild type Bcl-X(L), promotes clonogenic survival after ionizing radiation.
    Rehemtulla A; Hamilton AC; Taneja N; Fridman J; Juan TS; Maybaum J; Chinnaiyan A
    Neoplasia; 1999 Apr; 1(1):63-70. PubMed ID: 10935471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
    Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression.
    Strasser-Wozak EM; Hartmann BL; Geley S; Sgonc R; Böck G; AJ Santos ; Hattmannstorfer R; Wolf H; Pavelka M; Kofler R
    Cell Death Differ; 1998 Aug; 5(8):687-93. PubMed ID: 10200524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH; Shi Q; Wang JF; Chen YJ; Zhuang YM; Pan JZ; Xu CS; Qi CJ; Zhang XG
    Apoptosis; 2005 Jan; 10(1):123-34. PubMed ID: 15711928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation.
    Milner AE; Grand RJ; Vaughan AT; Armitage RJ; Gregory CD
    Oncogene; 1997 Oct; 15(15):1815-22. PubMed ID: 9362448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas.
    Taylor ST; Hickman JA; Dive C
    Endocr Relat Cancer; 1999 Mar; 6(1):21-3. PubMed ID: 10732782
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.